This is a joint seminar series for two research programs, ATG and CAN-PRO. The seminars are held on Friday mornings starting with coffee, tea and cookies at 9:15 am. The presentations start at 9:30 am. We have two presentations per seminar.
Please see information for the speakers and contact info below the program.
Joonas Jukonen (Ojala group)
"MMP16 increases aggressiveness in melanomas bypassing sentinel lymph nodes"
Toni Lemmetyinen (Ollila group)
"Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth"
TBA (Vahteristo group)
Sadia Zafar (Ristimäki group)
Leticia Castillón (Vanharanta group)
Ville Tiusanen (Sahu group)
Pauliina Kallio (Alitalo group)
Maare Arffman (Leppä group)
"Inflamed serum protein profile associates with circulating tumor DNA levels and poor outcome in patients with high-risk large B-cell lymphoma"
Sanni Alve (Ojala group)
"Wnt5b is a novel mediator of pro-metastatic melanoma crosstalk with lymphatic endothelial cells"
Prima Sanjaya (Pitkänen group)
"Mutation-Attention (MuAt): deep representation learning of somatic mutations for tumour typing and subtyping”
Emma Viitala (Ollila group)
”scRNAseq data mining and ex vivo methods to map intestinal stromal-epithelial interactions in health and disease”
Marika Lassila (Alitalo group)
“The function of Tcf1 (Tcf7) in intestinal adenoma development”
Päivi Sulo (Aaltonen group)
"Genome wide annotation of transposable elements from Nanopore data”
Liangru Fei (Sahu group)
"Control of pancreatic cell fate by defined transcription factors''
Inam Liaqat (Vaahtomeri group)
"Guidance of antigen-presenting dendritic cells across lymphatic endothelium"
Anne Pink (Saharinen group)
"The integrin inhibitor SHARPIN regulates endothelial permeability via balancing cell-cell and cell-matrix adhesion"
Anna Äyräväinen (Vahteristo group)
”Quality of life and clinical outcome after laparoscopic and abdominal myomectomy”
Artemis Filippou (Monni group)
“Liprin-α1 contributes to oncogenic MAPK signaling and associates with MEK/ERK inhibitor response”
Abiodun Ayo (Laakkonen group)
"The central nervous system (CNS) tumor homing peptides as novel theranostic tools"
Krista Tuohinto (Ojala group)
"Lymphatic transcription factor SOX18 as a viable molecular target for viral cancer Kaposi's sarcoma"
Vilja Jokinen (Aaltonen group)
"Inherited mutations in SRCAP complex genes predispose to uterine leiomyomas with moderate penetrance"
Yepeng Du (Taipale group)
"Decrease cancer’s reliance on Myc gene to control cell proliferation"
Eva Domenech Moreno (Ollila group)
"LKB1 is a gatekeeper of an IL-11 dependent tumor-promoting phenotype in fibroblasts"
Konsta Karttunen (Sahu group)
"Transposable elements as tissue-specific enhancers in cancers of endodermal lineage"
Emma Jakobsson (Vaahtomeri group)
"Mechanisms that ensure lymphatic vessel network tissue coverage"
Aino Peura (Klefström group)
"Micromechanical Regulation of Tumor Immune Microenvironment"
Aurora Taira (Aaltonen group)
"Boosting DNA demethylation with vitamin C - a clinical trial of one year"
Pauliina Kallio (Alitalo group)
"PROX1 marks colorectal cancer stem cells and protects them from radiation-induced damage"
Yepeng Du (Taipale group)
"Finding alternative transcription factor via CGE (competitive gene editing) assay to regulate critical Myc controlled genes"
Laura Langohr (Kilpivaara group & Pitkänen group)
"Single-cell analysis reveals somatic TP53 mutations emerge in early progenitor cells but become enriched in the erythroid lineage in ERCC6L2 disease"
Cinzia Bessone (Alitalo group)
"Prox1 transcription factor in colorectal cancer and intestinal cell lineage commitment during development"
Selma Sorri (Leppä group)
"Oncogenic Mutational Disruption of KLHL6 Dimers Fuels B-cell Receptor Signaling in Aggressive B-cell Lymphoma"
Please plan your talk to last for 20 minutes, including at least a 5 minutes long introduction. After the presentation, there will be 10 minutes for discussion. Please bring your presentation on a USB device.
Each presentation is preceded by a short introduction (5 minutes) of the topic/presenter by the supervisor/PI
1 ECTS (10 attended seminars) + 1 ECTS from own presentation.
Note! You do not need to attend seminars within one year. In order to get the credits from your own presentation, you need to attend 10 seminars.
Contact persons are Petri Mäkelä (ATG) and Saija Piiroinen (CAN-PRO).